Andrew Brenner Selected Research

Trastuzumab (Herceptin)

1/2021

Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Brenner Research Topics

Disease

17	Neoplasms (Cancer) 01/2023 - 02/2012
12	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 01/2016
7	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2019
3	Neoplasm Metastasis (Metastasis) 04/2024 - 10/2014
3	Brain Neoplasms (Brain Tumor) 01/2021 - 02/2012
3	Glioma (Gliomas) 01/2016 - 05/2012
2	Fatigue 04/2021 - 03/2013
2	Lymphoma (Lymphomas) 01/2020 - 10/2019
1	Astrocytoma (Pilocytic Astrocytoma) 01/2023
1	Obesity 01/2022
1	Nausea 04/2021
1	Alopecia (Baldness) 04/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2021
1	Microsatellite Instability 01/2020
1	Carcinogenesis 01/2019
1	Genomic Instability 01/2019
1	Medulloblastoma 10/2018
1	Meningioma (Meningiomas) 09/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Infections 06/2014
1	Neutropenia 03/2013
1	Ovarian Neoplasms (Ovarian Cancer) 02/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2012

Drug/Important Bio-Agent (IBA)

6	Estrogen ReceptorsIBA 01/2023 - 05/2012
4	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2018
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2023 - 04/2021
3	Estrogens (Estrogen)FDA Link 01/2022 - 05/2012
2	TVB-2640IBA 01/2023 - 04/2021
2	LipidsIBA 01/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	taxaneIBA 04/2021 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 03/2013 - 02/2012
2	paclitaxel-Angiopep-2 conjugateIBA 03/2013 - 02/2012
2	Peptides (Polypeptides)IBA 03/2013 - 02/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2013 - 02/2012
1	RheniumIBA 04/2024
1	Rhenium-186IBA 12/2023
1	Radioisotopes (Radionuclides)IBA 12/2023
1	Nonesterified Fatty Acids (NEFA)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Gadolinium DTPA (Magnevist)FDA Link 01/2023
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2023
1	Proto-Oncogene Proteins c-etsIBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	Contrast MediaIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	4- (1- (5- (3,4- dimethyl- 1H- pyrazol- 5- yl)- 2,4- dimethylbenzoyl)azetidin- 3- yl)benzonitrileIBA 01/2022
1	carbazoleIBA 01/2022
1	olaparibIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	EnzymesIBA 01/2022
1	Imipramine (Janimine)FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	tucatinibIBA 01/2021
1	Immunotoxins (Immunotoxin)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	N 30IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 10/2019
1	Estrogen Receptor betaIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	Vincristine (Oncovin)FDA LinkGeneric 10/2018
1	TH 302IBA 01/2018
1	Alkylating AgentsIBA 01/2018
1	isophosphamide mustard (IPAM)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	ProdrugsIBA 01/2018
1	erteberelIBA 01/2016
1	AlbuminsIBA 10/2014
1	Immunoglobulin M (IgM)IBA 06/2014
1	Immunoglobulin G (IgG)IBA 06/2014
1	liquiritigeninIBA 05/2012
1	CarcinogensIBA 05/2012
1	Angiopep-2IBA 02/2012

Therapy/Procedure

13	Therapeutics 12/2023 - 02/2012
3	Drug Therapy (Chemotherapy) 01/2022 - 05/2012
1	Immunotherapy 01/2021
1	Radiotherapy 09/2018